Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis
暂无分享,去创建一个
Pierre Baldi | Paolo Sassone-Corsi | P. Baldi | T. Jacks | P. Sassone-Corsi | Yu Liu | T. Papagiannakopoulos | Tyler Jacks | Selma Masri | Thales Papagiannakopoulos | Kenichiro Kinouchi | Yu Liu | Marlene Cervantes | S. Masri | M. Cervantes | Kenichiro Kinouchi
[1] R. Medzhitov,et al. The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia , 2016, Cell.
[2] Paolo Sassone-Corsi,et al. Time for Food: The Intimate Interplay between Nutrition, Metabolism, and the Circadian Clock , 2015, Cell.
[3] J. Durstine,et al. Liver Inflammation and Metabolic Signaling in ApcMin/+ Mice: The Role of Cachexia Progression , 2015, PloS one.
[4] J. Mauer,et al. Versatile functions for IL-6 in metabolism and cancer. , 2015, Trends in immunology.
[5] P. Sassone-Corsi,et al. Circadian clocks, epigenetics, and cancer , 2015, Current opinion in oncology.
[6] Hua Yu,et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.
[7] G. Cline,et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid , 2014, Nature.
[8] M. Pichler,et al. Corrigendum to “Tumor Macroenvironment and Metabolism” [Seminars in Oncology, Vol 41, No 2, April 2014, pp 281–295] , 2014, Seminars in oncology.
[9] K. Gamble,et al. Circadian clock control of endocrine factors , 2014, Nature Reviews Endocrinology.
[10] Pierre Baldi,et al. Partitioning Circadian Transcription by SIRT6 Leads to Segregated Control of Cellular Metabolism , 2014, Cell.
[11] M. Pichler,et al. Tumor Macroenvironment and Metabolism , 2014, Seminars in oncology.
[12] R. Zechner,et al. Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation , 2014, PloS one.
[13] N. Guex,et al. Genome-Wide Analysis of SREBP1 Activity around the Clock Reveals Its Combined Dependency on Nutrient and Circadian Signals , 2014, PLoS genetics.
[14] J. Takahashi,et al. Molecular architecture of the mammalian circadian clock. , 2014, Trends in cell biology.
[15] Pierre Baldi,et al. Reprogramming of the Circadian Clock by Nutritional Challenge , 2013, Cell.
[16] John L Cleveland,et al. Targeting lactate metabolism for cancer therapeutics. , 2013, Journal of Clinical Investigation.
[17] J. Bass,et al. Circadian topology of metabolism , 2012, Nature.
[18] Satchidananda Panda,et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. , 2012, Cell metabolism.
[19] L. Cantley,et al. Cancer Cell Metabolism , 2012 .
[20] A. Loudon,et al. The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines , 2011, Proceedings of the National Academy of Sciences.
[21] B. Gao,et al. Inflammation‐associated interleukin‐6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin‐10–deficient mice , 2011, Hepatology.
[22] T. Zimmers,et al. STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia , 2011, PloS one.
[23] H. Pilegaard,et al. Interleukin‐6 modifies mRNA expression in mouse skeletal muscle , 2011, Acta physiologica.
[24] Z. Varghese,et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis , 2011, Journal of gastroenterology and hepatology.
[25] Shizuo Akira,et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. , 2011, Cancer cell.
[26] Mengwei Zang,et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. , 2011, Cell metabolism.
[27] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[28] Sofianos Andrikopoulos,et al. Liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1 , 2010, Hepatology.
[29] Paolo Sassone-Corsi,et al. Plasticity and specificity of the circadian epigenome , 2010, Nature Neuroscience.
[30] Dmitri A. Nusinow,et al. Cryptochrome Mediates Circadian Regulation of cAMP Signaling and Hepatic Gluconeogenesis , 2010, Nature Medicine.
[31] T. Okanoue,et al. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice , 2010, Laboratory Investigation.
[32] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[33] S. Panda,et al. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression , 2009, Proceedings of the National Academy of Sciences.
[34] Paolo Sassone-Corsi,et al. Metabolism and cancer: the circadian clock connection , 2009, Nature Reviews Cancer.
[35] Ueli Schibler,et al. REV-ERBα Participates in Circadian SREBP Signaling and Bile Acid Homeostasis , 2009, PLoS biology.
[36] Corey D. DeHaven,et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.
[37] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[38] M. Karin,et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.
[39] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[40] Z. Varghese,et al. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice , 2008, Hepatology.
[41] W. Gerald,et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. , 2007, The Journal of clinical investigation.
[42] D. Santini,et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.
[43] Kathryn Moynihan Ramsey,et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. , 2007, Cell metabolism.
[44] Wan-Wan Lin,et al. A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.
[45] A. Yoshimura,et al. The dual function of hepatic SOCS3 in insulin resistance in vivo , 2007, Genes to cells : devoted to molecular & cellular mechanisms.
[46] B. Pedersen,et al. Interleukin-6 Regulation of AMP-Activated Protein Kinase , 2006, Diabetes.
[47] D. James,et al. Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase , 2006, Diabetes.
[48] Helen H. W. Chen,et al. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion , 2006, Oncogene.
[49] T. Jacks,et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. , 2005, Cancer research.
[50] U. Markert,et al. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. , 2005, The international journal of biochemistry & cell biology.
[51] B. Pedersen,et al. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.
[52] K. Syrigos,et al. Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer , 2004, British Journal of Cancer.
[53] Jay D. Horton,et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[54] L. Fu,et al. The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.
[55] T. Zimmers,et al. Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes* , 2003, The Journal of Biological Chemistry.
[56] M. White,et al. SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.
[57] B. H. Miller,et al. Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock , 2002, Cell.
[58] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[59] E. Van Obberghen,et al. SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice* , 2001, The Journal of Biological Chemistry.
[60] J. Miyazaki,et al. Tissue-Specific Autoregulation of thestat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells , 2001, Molecular and Cellular Biology.
[61] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[62] Y Sakaki,et al. Entrainment of the circadian clock in the liver by feeding. , 2001, Science.
[63] F. Fleury-Olela,et al. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. , 2000, Genes & development.
[64] L. Pfeffer,et al. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. , 1998, Journal of immunology.
[65] J. Darnell. STATs and gene regulation. , 1997, Science.
[66] B. Kemp,et al. Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.
[67] J. Goldstein,et al. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.
[68] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.